These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10687670)

  • 1. The importance of considering trial design when interpreting clinical trial results.
    Reiffel JA
    J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):17-25. PubMed ID: 10687670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee.
    Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527
    [No Abstract]   [Full Text] [Related]  

  • 3. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent trends in anti-arrhythmia therapy].
    Ogawa S
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):439-41. PubMed ID: 7751785
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for cardiac arrhythmias.
    Treat Guidel Med Lett; 2004 Nov; 2(27):75-82. PubMed ID: 15529117
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of life in patients with life-threatening arrhythmias: does choice of therapy make a difference?
    Exner DV
    Am Heart J; 2002 Aug; 144(2):208-11. PubMed ID: 12177635
    [No Abstract]   [Full Text] [Related]  

  • 7. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implantable cardioverter-defibrillator: does everybody need one?
    Raj SR; Sheldon RS
    Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AVID trial--another embarrassment.
    Nomof N
    Am J Cardiol; 1998 Feb; 81(4):530. PubMed ID: 9485153
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillators.
    DiMarco JP
    N Engl J Med; 2003 Nov; 349(19):1836-47. PubMed ID: 14602883
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICD therapy: what have we learned from the clinical trials?
    Arya A; Haghjoo M; Sadr-Ameli MA
    Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
    Eckardt L; Breithardt G
    Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
    [No Abstract]   [Full Text] [Related]  

  • 14. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 15. The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1994 Jun; 15(6):721-38. PubMed ID: 8088260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Arrhythmias and Pacing 2015: A Selection of Topical Issues.
    Peinado R; Ruiz-Mateas F; Izquierdo M; Arana E; Robledo M; Arias MA; Jiménez-Jáimez J; Rodríguez-Mañero M; Chimeno J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):167-75. PubMed ID: 26778594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT).
    Connolly SJ; Philippon F; Longtin Y; Casanova A; Birnie DH; Exner DV; Dorian P; Prakash R; Alings M; Krahn AD
    Can J Cardiol; 2013 Jun; 29(6):652-8. PubMed ID: 23702356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 20. Ventricular arrhythmias in heart failure.
    Batsford WP; Mickleborough LL; Elefteriades JA
    Cardiol Clin; 1995 Feb; 13(1):87-91. PubMed ID: 7796435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.